@prefix np: . @prefix npx: . @prefix ns1: . @prefix ns2: . @prefix ns3: . @prefix orcid: . @prefix prov: . @prefix rdf: . @prefix rdfs: . @prefix sub: . @prefix this: . @prefix xsd: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { ns1:consider . } sub:provenance { sub:_assertion prov:wasGeneratedBy "S&T TWOC Project - version 4", "S&T TWOC version 3" . sub:_version prov:value "2"^^xsd:integer . sub:assertion prov:generatedAtTime "2023-07-20T09:47:28.479517"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0003-4692-1377; prov:wasDerivedFrom . rdf:OBJECT rdfs:label "in case of ARDS" . rdf:OBJECT-POSITION rdfs:label "(18, 29)" . rdf:PREDICATE rdfs:label "considered" . rdf:PREDICATE-POSITION rdfs:label "35" . rdf:SUBJECT rdfs:label "Dexamethasone and tocilizumab" . rdf:SUBJECT-POSITION rdfs:label "(18, 29)" . rdf:Statement rdfs:label "Dexamethasone and tocilizumab were considered in case of ARDS." . rdfs:ABSTRACT-UID ns2:50 "esjmr1is" . rdfs:TRIPLE-UID ns3:esjmr1is-TRIPLE-ABSTRACT-1 "esjmr1is-TRIPLE-ABSTRACT-1" . rdfs:label "tocilizumab" . rdfs:label "case" . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "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"; npx:hasSignature "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"; npx:hasSignatureTarget this: . this: prov:wasAttributedTo orcid:0000-0003-4692-1377 . }